Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02427724 · ClinicalTrials.gov registry record · Early Phase 1
The Effect of Topical Anesthetics on Patients' Pain and Operative Experience During Treatment With QSwitched Laser
A Early Phase 1 study of Lentigo, sponsored by Northwestern University.
- Active
- Registry status
- Early Phase 1
- Development phase
- 48
- Enrollment target
- 1
- Study location
NCT02427724 is a Early Phase 1 study of Lentigo that is active but no longer recruiting, run by Northwestern University. The registered enrollment target is 48 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02427724, a Early Phase 1 study of Lentigo, is active but no longer recruiting, sponsored by Northwestern University.
- ACTIVE NOT RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 48 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will conduct a split-face and -body randomized control trial to compare lidocaine 2.5%/prilocaine 2.5% topical anesthetic (LPTA), lidocaine 7%/tetracaine 7% topical anesthetic (LTTA), and placebo vechicle (PV) on patients' pain perceptions with Q-switched 532nm laser for the treatment of lentigines and/or photorejuvenation.Subjects will fill out a pain score on a visual analog scale (VAS) with 0 being no pain and 10 being most pain after each treatment area is completed.
Conditions Studied
Interventions
- DRUG lidocaine 2.5%/prilocaine 2.5% topical anesthetic
- DRUG lidocaine 7%/tetracaine 7% topical anesthetic
- DRUG placebo vehicle
- DEVICE Q-switched 532nm Laser
Study Locations (1)
Illinois
- Northwestern University Feinberg School of Medicine, Department of Dermatology - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2015-04 |
| Est. Completion | 2025-12 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02427724
The ClinicalTrials.gov registry entry for NCT02427724 describes a study currently listed as active not recruiting, categorized as Early Phase 1. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lentigo appearing as the primary indexed condition, and to 4 interventions - of which lidocaine 2.5%/prilocaine 2.5% topical anesthetic is the first listed.
NCT02427724 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT02427724 about?
NCT02427724 is a clinical study titled "The Effect of Topical Anesthetics on Patients' Pain and Operative Experience During Treatment With QSwitched Laser". This study will conduct a split-face and -body randomized control trial to compare lidocaine 2.5%/prilocaine 2.5% topical anesthetic (LPTA), lidocaine 7%/tetracaine 7% topical anesthetic (LTTA), and placebo vechicle (PV) on patients' pain perceptions with Q-switched 532nm laser for the treatment of ...
What is the current status of trial NCT02427724?
This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 48 participants. The study started on 2015-04. Estimated completion is 2025-12.
What conditions does trial NCT02427724 study?
This clinical trial studies the following conditions: Lentigo.
What interventions are being tested in trial NCT02427724?
The interventions under investigation include: lidocaine 2.5%/prilocaine 2.5% topical anesthetic (DRUG), lidocaine 7%/tetracaine 7% topical anesthetic (DRUG), placebo vehicle (DRUG), Q-switched 532nm Laser (DEVICE).
Who is sponsoring clinical trial NCT02427724?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02427724 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.